From studying DNA in the lab to working with patients in clinical trials, Amgen scientists are pioneering new approaches to understanding human biology and making innovative medicines to treat disease. Join leaders at Amgen and beyond for in-depth discussions of the latest science and discoveries in our podcasts developed in collaboration with The Scientist.
Out Now: The Generative Biology Revolution
Generative biology is a revolutionary approach to drug discovery and development that leverages AI and machine learning to design novel protein therapeutics. It holds the potential to enhance the speed and efficiency of drug discovery.
In this four-part series, Ray Deshaies, senior vice president of Global Research at Amgen, discusses how generative biology is transforming drug discovery to make it more predictable, shorten timelines, and increase success rates of bringing life-saving medicines to patients who need them most.
Launched June 23, 2022
The Cresting Wave of Transformational Science
with Alan Russell, Ph.D., vice president of Biologics
The Protein Structure Prediction Problem
with Mike Nohaile, Ph.D., Chief Scientific Officer, Generate Biomedicines
with David Baker, Ph.D., Institute for Protein Design, University of Washington
Accelerating Drug Discovery
with Suzanne Edavettal, Ph.D., executive director of Protein Engineering
In this five-part series, Ray Deshaies hosts conversations with leading scientists to take a deep dive into the most promising new ways to treat disease as we enter a fourth wave of innovation. Listen in to learn how the current wave of discovery, led by new types of multispecific medicines, has the potential to radically alter our concept of how drugs can work and pave the way for new solutions.
The Next Wave of Drug Development
with Ryan Potts, Ph.D., executive director, Research and head of Induced Proximity Platform at Amgen
The Biology of PROTACs
with Craig Crews, Ph.D., professor of Molecular, Cellular and Developmental Biology, Yale
Discovery at the DNA Encoded Library
with Alex Gouliaev, Ph.D., vice president, Amgen Research Copenhagen
The emerging IPP toolkit
with Carolyn Bertozzi, Ph.D., professor of Chemistry, Stanford
Induced Proximity: Reason for Optimism in Treating Cancer and Beyond
with David Reese, M.D., executive vice president, Research and Development, Amgen
DNA Unlocked, a 5-part podcast series about the twists and turns, highs and lows of the quest to generate insights from DNA sequencing that will solve some of the most challenging questions in the biology of disease.
Join host Ray Deshaies to go deep on how scientists are approaching the mountains of genomic data to tackle longstanding barriers to drug discovery, unlock cancer, and learn first-hand about exciting ideas 'coming around the bend.'
Reshaping the Future
with Amit V. Khera, M.D., MGH Center for Genomic Medicine
Unlocking the Genetics of Cancer
with Angela Coxon, Ph.D., vice president of Oncology Research at Amgen
with Larry Gold, Ph.D., founder of Somalogic
Genetics vs. Biology
with Saptarsi Haldar, M.D., vice president of Cardiometabolic Research at Amgen
Promise and the Potential
with Richard Scheller, Ph.D., former chief scientific officer of 23andMe and former executive vice president of Research and Early Development at Genentech